Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F9RE
|
||||
| Former ID |
DNC000175
|
||||
| Drug Name |
Allylamines
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Formula |
C3H7N
|
||||
| CAS Number |
CAS 30551-89-4
|
||||
| Target and Pathway | |||||
| Target(s) | Squalene monooxygenase | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Steroid biosynthesis | ||||
| Sesquiterpenoid and triterpenoid biosynthesis | |||||
| Metabolic pathways | |||||
| Biosynthesis of secondary metabolites | |||||
| Biosynthesis of antibiotics | |||||
| PathWhiz Pathway | Steroid Biosynthesis | ||||
| Reactome | Cholesterol biosynthesis | ||||
| Activation of gene expression by SREBF (SREBP) | |||||
| References | |||||
| REF 1 | Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine. Arch Biochem Biophys. 1997 Apr 15;340(2):265-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.